CURA FOUNDATION
Programs
Program 1 [2019]
THE FOUNDATION RAISES GLOBAL AWARENESS ABOUT DISEASE PREVENTION AND CELL THERAPY TREATMENT AND FOSTERS A COLLABORATIVE DIALOGUE BETWEEN SCIENTISTS, REGULATORY AGENCIES, MINISTERS OF HEALTH, PATIENT ADVOCATES, PHYSICIANS, ETHICISTS, PHILANTHROPISTS, LEADERS OF FAITH, GOVERNMENT OFFICIALS AND INDUSTRY PERSONNEL. THE FOUNDATION ALSO EDUCATES OUR NEXT GENERATION OF THOUGHT LEADERS ABOUT THE RAPID INNOVATION IN CELL THERAPY TECHNOLOGY AND THE IMPORTANCE TO INTERFACE WITH DATA TO IMPROVE CLINICAL OUTCOMES AND OPTIMIZE HEALTH CARE SPENDING. ITS MANAGEMENT, BOARD AND COLLABORATORS LOOK FOR WAYS TO SPEED CLINICAL DEVELOPMENT AND UTILIZE BIG DATA AND ALGORITHMIC LEARNING TO ADVANCE PERSONALIZED MEDICINES, SO THAT PATIENTS CAN RECEIVE THE BEST POSSIBLE TREATMENT FOR THEIR INDIVIDUAL DISEASES AS QUICKLY AS POSSIBLE, RATIONALIZING HEALTHCARE DOLLAR SPENT WHILE IMPROVING CLINICAL OUTCOMES.GeographiesNot indicatedDatesJan 1, 2019 – Dec 31, 2019Source990No causes providedNo populations provided–$886.1KCell Therapy Awareness and Education
THE FOUNDATION RAISES GLOBAL AWARENESS ABOUT DISEASE PREVENTION AND CELL THERAPY TREATMENT AND FOSTERS A COLLABORATIVE DIALOGUE BETWEEN SCIENTISTS, REGULATORY AGENCIES, MINISTERS OF HEALTH, PATIENT ADVOCATES, PHYSICIANS, ETHICISTS, PHILANTHROPISTS, LEADERS OF FAITH, GOVERNMENT OFFICIALS AND INDUSTRY PERSONNEL. THE FOUNDATION ALSO EDUCATES OUR NEXT GENERATION OF THOUGHT LEADERS ABOUT THE RAPID INNOVATION IN CELL THERAPY TECHNOLOGY AND THE IMPORTANCE TO INTERFACE WITH DATA TO IMPROVE CLINICAL OUTCOMES AND OPTIMIZE HEALTH CARE SPENDING. ITS MANAGEMENT, BOARD AND COLLABORATORS LOOK FOR WAYS TO SPEED CLINICAL DEVELOPMENT AND UTILIZE BIG DATA AND ALGORITHMIC LEARNING TO ADVANCE PERSONALIZED MEDICINES, SO THAT PATIENTS CAN RECEIVE THE BEST POSSIBLE TREATMENT FOR THEIR INDIVIDUAL DISEASES AS QUICKLY AS POSSIBLE, RATIONALIZING HEALTHCARE DOLLAR SPENT WHILE IMPROVING CLINICAL OUTCOMES.GeographiesNot indicatedDatesJan 1, 2022 – Dec 31, 2022Source990No causes providedNo populations provided–$1.4M
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)